Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
Clinical trial NCT02638389 · RECRUITING
Trial details
- NCT number
- NCT02638389
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-25
- Primary completion
- 2025-04-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.